Mu L - Search Results

1

High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.

Qian B, Katsaros D, Lu L, Preti M, Durando A, Arisio R, Mu L, Yu H. Qian B, et al. Among authors: mu l. Breast Cancer Res Treat. 2009 Sep;117(1):131-40. doi: 10.1007/s10549-008-0219-7. Epub 2008 Oct 19. Breast Cancer Res Treat. 2009. PMID: 18932017

2

Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.

Mu L, Katsaros D, Wiley A, Lu L, de la Longrais IA, Smith S, Khubchandani S, Sochirca O, Arisio R, Yu H. Mu L, et al. Breast Cancer Res Treat. 2009 May;115(1):151-62. doi: 10.1007/s10549-008-0046-x. Epub 2008 May 15. Breast Cancer Res Treat. 2009. PMID: 18481170

3

TGF-beta1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival.

Mu L, Katsaros D, Lu L, Preti M, Durando A, Arisio R, Yu H. Mu L, et al. Br J Cancer. 2008 Oct 21;99(8):1357-63. doi: 10.1038/sj.bjc.6604689. Epub 2008 Sep 30. Br J Cancer. 2008. PMID: 18827819 Free PMC article.

4

The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer.

Yi C, Mu L, de la Longrais IA, Sochirca O, Arisio R, Yu H, Hoffman AE, Zhu Y, Katsaro D. Yi C, et al. Among authors: mu l. Breast Cancer Res Treat. 2010 Apr;120(3):663-9. doi: 10.1007/s10549-009-0484-0. Epub 2009 Aug 1. Breast Cancer Res Treat. 2010. PMID: 19649706 Free PMC article.

5

Let-7a regulation of insulin-like growth factors in breast cancer.

Lu L, Katsaros D, Zhu Y, Hoffman A, Luca S, Marion CE, Mu L, Risch H, Yu H. Lu L, et al. Among authors: mu l. Breast Cancer Res Treat. 2011 Apr;126(3):687-94. doi: 10.1007/s10549-010-1168-5. Epub 2010 Sep 17. Breast Cancer Res Treat. 2011. PMID: 20848182

6

Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1.

Zeng H, Irwin ML, Lu L, Risch H, Mayne S, Mu L, Deng Q, Scarampi L, Mitidieri M, Katsaros D, Yu H. Zeng H, et al. Among authors: mu l. Breast Cancer Res Treat. 2012 May;133(1):127-35. doi: 10.1007/s10549-011-1716-7. Epub 2011 Aug 12. Breast Cancer Res Treat. 2012. PMID: 21837478

7

Favorable outcome associated with an IGF-1 ligand signature in breast cancer.

Mu L, Tuck D, Katsaros D, Lu L, Schulz V, Perincheri S, Menato G, Scarampi L, Harris L, Yu H. Mu L, et al. Breast Cancer Res Treat. 2012 May;133(1):321-31. doi: 10.1007/s10549-012-1952-5. Breast Cancer Res Treat. 2012. PMID: 22297468

8

Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer.

Lu L, Zhu G, Zhang C, Deng Q, Katsaros D, Mayne ST, Risch HA, Mu L, Canuto EM, Gregori G, Benedetto C, Yu H. Lu L, et al. Among authors: mu l. Breast Cancer Res Treat. 2012 Dec;136(3):875-83. doi: 10.1007/s10549-012-2314-z. Epub 2012 Nov 3. Breast Cancer Res Treat. 2012. PMID: 23124417

9

Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population.

Mu LN, Lu QY, Yu SZ, Jiang QW, Cao W, You NC, Setiawan VW, Zhou XF, Ding BG, Wang RH, Zhao J, Cai L, Rao JY, Heber D, Zhang ZF. Mu LN, et al. Int J Cancer. 2005 Oct 10;116(6):972-83. doi: 10.1002/ijc.21137. Int J Cancer. 2005. PMID: 15856451 Free PMC article.

10

Indices of Diet Quality and Risk of Lung Cancer in the Women's Health Initiative Observational Study.

Myneni AA, Giovino GA, Millen AE, LaMonte MJ, Wactawski-Wende J, Neuhouser ML, Zhao J, Shikany JM, Mu L. Myneni AA, et al. Among authors: mu l. J Nutr. 2021 Jun 1;151(6):1618-1627. doi: 10.1093/jn/nxab033. J Nutr. 2021. PMID: 33982106 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,801 results

Search Page

Filters